Investigation of poststroke epilepsy (INPOSE) study: a multicenter prospective study for prediction of poststroke epilepsy.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 04 2020
accepted: 05 06 2020
revised: 03 06 2020
pubmed: 21 6 2020
medline: 22 6 2021
entrez: 21 6 2020
Statut: ppublish

Résumé

Poststroke epilepsy is a common problem in clinical practice. This study aimed to determine the predictors of poststroke epilepsy and to identify the risk factors. A total of 436 patients were enrolled for this study. Baseline characteristics were recorded. Patients were followed up for 3 years. According to the occurrence of late seizures (i.e., seizure occurring 8 days or later after the stroke), the patients were separated into two groups: a seizure group and a seizure-free group. Baseline characteristics were compared between the groups. Univariate and multivariate Cox regression analysis was used to identify the risk factors for occurrence of poststroke epilepsy. The study was registered in the University Hospital Medical Information Network Center Clinical Trials Registry (registration number UMIN000009659, date 28/December/2012). Among the 436 patients, 26 developed late seizures-an incidence rate of 5.96%. In univariate analysis, female, subarachnoid hemorrhage, hemorrhagic lesion, lesion affecting the cortex, lesion affecting the frontal lobe, and absence of comorbidities were the significant risk factors for occurrence of epilepsy. In multivariate analysis, the independent predictors of poststroke epilepsy were hemorrhagic lesion (hazard ratio (HR) = 3.03) and lesion location in the cortex (HR = 4.64). The incidence of poststroke epilepsy in patients with both two risk factors was 15.4%. Poststroke epilepsy occurs in almost 6% of patients within 3 years after stroke onset. Hemorrhagic stroke and subcortical lesion appear to be significantly associated with likelihood of developing epilepsy. Thus, prophylactic administration of antiepileptic drugs could be useful for stroke patients with these two risk factors.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Poststroke epilepsy is a common problem in clinical practice. This study aimed to determine the predictors of poststroke epilepsy and to identify the risk factors.
METHODS METHODS
A total of 436 patients were enrolled for this study. Baseline characteristics were recorded. Patients were followed up for 3 years. According to the occurrence of late seizures (i.e., seizure occurring 8 days or later after the stroke), the patients were separated into two groups: a seizure group and a seizure-free group. Baseline characteristics were compared between the groups. Univariate and multivariate Cox regression analysis was used to identify the risk factors for occurrence of poststroke epilepsy. The study was registered in the University Hospital Medical Information Network Center Clinical Trials Registry (registration number UMIN000009659, date 28/December/2012).
RESULTS RESULTS
Among the 436 patients, 26 developed late seizures-an incidence rate of 5.96%. In univariate analysis, female, subarachnoid hemorrhage, hemorrhagic lesion, lesion affecting the cortex, lesion affecting the frontal lobe, and absence of comorbidities were the significant risk factors for occurrence of epilepsy. In multivariate analysis, the independent predictors of poststroke epilepsy were hemorrhagic lesion (hazard ratio (HR) = 3.03) and lesion location in the cortex (HR = 4.64). The incidence of poststroke epilepsy in patients with both two risk factors was 15.4%.
CONCLUSIONS CONCLUSIONS
Poststroke epilepsy occurs in almost 6% of patients within 3 years after stroke onset. Hemorrhagic stroke and subcortical lesion appear to be significantly associated with likelihood of developing epilepsy. Thus, prophylactic administration of antiepileptic drugs could be useful for stroke patients with these two risk factors.

Identifiants

pubmed: 32561989
doi: 10.1007/s00415-020-09982-2
pii: 10.1007/s00415-020-09982-2
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3274-3281

Auteurs

Shuichi Yamada (S)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan. syamada@naramed-u.ac.jp.

Ichiro Nakagawa (I)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan.

Kentaro Tamura (K)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan.

Fumihiko Nishimura (F)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan.

Yasushi Motoyama (Y)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan.

Young-Soo Park (YS)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan.

Hiroyuki Nakase (H)

Department of Neurosurgery, Nara Medical University, 840, Shijo-cho, Kashihara, Nara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH